Clague Laura
SEC CIK 1388773 · EDGAR
BoughtSold
Most active insiders at LAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Casdin Partners GP, LLC | Dir, 10% | $11.41M | — |
| 2 | Casdin Eli | Dir, 10% | $1.37M | — |
| 3 | Casdin Partners Master Fund, L.P. | Dir, 10% | $1.12M | — |
| 4 | CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC | Dir | $503.0K | — |
| 5 | Kim Hanjoon Alex | CFO | — | — |
| 6 | Mackay Sean | SVP, Chief Business Off | — | — |
| 7 | Cox Troy | Dir | — | — |
| 8 | Carey Thomas D. | Dir | — | — |
| 9 | Egholm Michael | Pres, CEO, Dir | — | — |
| 10 | Witney Frank | Dir | — | — |
Clague Laura made no open-market trades at LAB in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-14 | LAB | STANDARD BIOTOOLS INC. | Clague Laura | Dir | A - Grant | $0.00 | +26.4K | 104.8K | +34% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | STANDARD BIOTOOLS INC. | Clague Laura | Dir | A - Grant | $0.00 | +30.9K | 78.4K | +65% | $0 |
| M | 2022-05-12 | 2022-05-10+ | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | S - Sale | $21.51 | -2,200 | 35.7K | -6% | -$47.3K |
| D | 2022-04-27 | 2022-04-27 | GNSS | Genasys Inc. | Clague Laura | Dir | M - OptEx | $1.33 | +50.0K | 284.3K | +21% | +$66.5K |
| 2022-03-17 | 2022-03-15 | GNSS | Genasys Inc. | Clague Laura | Dir | A - Grant | — | +30.0K | 234.3K | +15% | — | |
| D | 2022-02-24 | 2022-02-23 | GNSS | Genasys Inc. | Clague Laura | Dir | M - OptEx | $2.16 | +20.0K | 218.0K | +10% | +$43.2K |
| D | 2022-02-24 | 2022-02-23 | GNSS | Genasys Inc. | Clague Laura | Dir | S - Sale+OE | $3.14 | -13.7K | 204.3K | -6% | -$43.1K |
| D | 2022-02-02 | 2022-01-31 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | A - Grant | $0.00 | +9,840 | 39.1K | +34% | $0 |
| D | 2022-02-02 | 2022-01-31 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | S - Sale | $27.40 | -1,238 | 37.9K | -3% | -$33.9K |
| 2022-01-26 | 2022-01-24 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | S - Sale | $24.98 | -2,063 | 29.3K | -7% | -$51.5K | |
| 2022-01-12 | 2022-01-10 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | A - Grant | $0.00 | +7,500 | 38.8K | +24% | $0 | |
| 2022-01-12 | 2022-01-11 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | S - Sale | $27.40 | -7,500 | 31.3K | -19% | -$205.5K | |
| 2021-08-17 | 2021-08-17 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | S - Sale | $17.12 | -1,407 | 31.3K | -4% | -$24.1K | |
| 2021-08-17 | 2021-08-13 | TVTX | Travere Therapeutics, Inc. | Clague Laura | CFO | A - Grant | $0.00 | +4,500 | 32.7K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations